Skip Navigation
 
Home | About CDC | Media Relations | A-Z Index | Contact Us
   
Centers for Disease Control & Prevention
CDC en Español 
Sexually Transmitted Diseases
Sexually Transmitted Diseases  >  Program Guidelines  >  Partner Services

Partner ServicesProgram Operations Guidelines for STD Prevention
Partner Services

Appendix PS-F

FIELD INVESTIGATIONS

It is the responsibility of the DIS to ensure that persons who have or are at risk of acquiring a STD receive appropriate medical care at the earliest possible time. The use of the telephone for initial follow-up activities can be an efficient use of DIS time, especially when calls are made in the early morning or evening hours. Telephones, however, are not valuable for in-depth investigation and confronting highly sensitive issues. Also be aware of caller ID and like technologies, as they may compromise confidentiality.

While the field investigation may require a greater initial investment of DIS time, it is the most effective follow-up method and frequently the most efficient as well. All field investigations should be conducted in unmarked vehicles.

It is incumbent upon the DIS to make the most efficient use of field time and to conduct each field investigation thoroughly to make the most of this activity.

  • To avoid duplication of effort and to expand locating information, the DIS should perform a record search immediately after initiating an investigation by reviewing available resources, including:
    1. open field investigation and case interview files;
    2. closed field investigation and case interview files;
    3. medical records;
    4. telephone white and yellow pages;
    5. directory assistance;
    6. cross directory; and
    7. computer locator resources.

The record(s) search and results should be completely documented on the back of the field record.

  • The DIS should begin investigative action on priority follow-ups within one workday of assignment or of DIS initiation.
  • When initial telephone attempts fail to reach the individual sought, or when the patient does not follow through with a commitment, the DIS should make a field visit within one working day or as directed by supervisor.
  • The DIS should prepare for field investigations by:
    • arranging investigations by investigative or intervention priority;
    • planning a route that addresses the greatest number of investigative priorities in the most efficient sequence;
    • including lower priority field activities that are near high-priority investigations;
    • consulting the supervisor on the potential for pooling work when distant locations are involved;
    • arranging work in the planned sequence at the front of the investigative pouch; and
    • preparing all referral notes before leaving for the field to improve efficiency and alertness.
  • Before leaving for the field, the DIS should assemble standard materials and supplies, including:
    1. investigative pouch;
    2. maps;
    3. venipuncture kit;
    4. writing materials (with spare pen);
    5. referral forms with envelopes;
    6. business cards;
    7. change for parking meter and public telephone (and telephone credit card, if available);
    8. identification card; and
    9. materials needed to perform field interviews, e.g., visual aids, consent forms.
  • The DIS should record the beginning and ending odometer readings and the distances between stops, as needed for travel reimbursement.
  • Before leaving the car for a field visit, the DIS should:
    1. review the field record and memorize all pertinent data to establish the precise objective(s) of the visit;
    2. observe the environment and anticipate obstacles to the investigation; and
    3. stow the pouch, confidential forms, and valuables in a secure place.
  • When there is no response at the door of the individual sought, the DIS should check for occupants at the side and back of the building when the way is not barred and it appears safe to do so.
  • When the individual sought is not found, the DIS should attempt to confirm the locating information in the initial visit by exploring all reasonable sources of information, such as:
    1. other persons encountered at the address;
    2. names on mailbox;
    3. neighbors, apartment managers, building superintendents;
    4. postal employees and other delivery personnel;
    5. local business people; and
    6. children in the area.
  • The DIS should gather patient locating information from sources in a manner which serves to improve upon the original data provided, including previously unknown information such as:
    1. full name and physical description;
    2. precise address, including apartment number;
    3. identity of co-residents;
    4. telephone number;
    5. type and place of employment;
    6. hours and habits;
    7. hangouts and associates;
    8. description of individual's car; and
    9. where the individual can be found now.
  • When locating information appears invalid, the DIS should transpose house and street numbers, etc., and checks similar locations in the immediate vicinity.
  • When the individual sought is encountered in the field, the DIS should convey a sense of urgency and motivate the patient to participate in the disease intervention process by:
    1. establishing the identity of the patient;
    2. engaging the patient in a private conversation;
    3. identifying self and conveying the reason for visit;
    4. establishing rapport and demonstrating concern;
    5. informing the patient of the STD at issue and of their risk status;
    6. clustering the patient for other high-risk persons; and
    7. referring the patient for the most immediate appropriate medical attention, which may include obtaining consent and collecting a specimen for testing.
  • When the individual wants care from a non-health department provider, the DIS should arrange or confirm the appointment personally. The DIS should tell both the health provider and the individual of the need for recommended testing, counseling, and treatment, and determine when the test results will be available. The DIS should try to get a signed release of information form from the patient, so that test results and treatment can be confirmed.
  • Even when the individual sought is not found, the field visit offers many advantages that can enhance disease intervention, such as:
    1. information about the individual's living situation, lifestyle, habits, or about the identity of cohabitants or co-residents, etc., may be gained, along with additional locating information;
    2. the DIS can leave a sealed referral notice that directs the individual to the first clinic session available;
    3. other high-risk persons may be identified; and,
    4. the validity of the provided locating information can be determined.
  • When the individual sought is not encountered at a confirmed place of residence, the DIS may leave a referral notice in a sealed envelope marked "personal" or "confidential." The DIS may add a personal note of urgency to the form. Referral notices may be left by the DIS with co-residents, building managers, employers, or under the door or in any area where the referral is protected and not accessible to children or casual visitors. Referral notices are not placed in or affixed to any mail box (U.S. Postal Service Code 1702, 1705, 1708, and 1725).
  • The DIS should not leave a third referral notice at the same address except with supervisor's consent.
  • When in a safe location, the DIS should document the results of the field investigation. The following information should be legibly, accurately, and concisely documented on the back of the investigative form with the use of accepted abbreviations and symbols:
    1. date and time of day;
    2. type activity (e.g. FV=field visit);
    3. persons encountered;
    4. results of investigation, which may include next planned action (date and type);
    5. referral specifics; and
    6. directions for difficult-to-find locations, when appropriate.
  • If practical, before returning to the office from distant locations, the DIS should contact the supervisor (or other designated team member) by telephone to inquire about emergent needs to which she or he should attend before returning.
  • The DIS should follow through on all commitments and pursue new information elicited during the course of investigations, as follows:
    1. confirms appointments made and kept (within one working day);
    2. re-initiates action within one working day when commitments fail; and,
    3. pursues new locating information within one working day.
  • When the original information fails to locate the individual, the DIS should seek to contact the source of the information at the first reasonable opportunity in order to correct or to expand locating data. Sources to contact include:
    1. the patient or others involved in a case;
    2. other case managers;
    3. health care providers; and
    4. Interstate Transmission of STD Intervention Information desk (according to established local procedures)
  • When there is no direct avenue to correct inadequate locating information, the DIS should discreetly accesses other agency resources, such as:
    1. Department of Motor Vehicles;
    2. Postal Service;
    3. utilities;
    4. Public Assistance;
    5. local schools;
    6. trade unions;
    7. law enforcement (jail rosters);
    8. voter registration;
    9. tax appraisal office;
    10. fire department (directory/department of streets);
    11. other health department programs (e.g. family planning, WIC, TB, etc.); and
    12. other community resources (e.g., hospitals, CBOs, etc.).
  • When an investigation stalls, the DIS should notify the supervisor or appropriate case manager at the earliest reasonable opportunity (not to exceed 72 hours). Supervisor's approval is needed to close unsuccessful investigations.
  • The DIS should complete and submit all assigned work to his or her supervisor before taking planned leave.

 

 



Page last modified: August 16, 2007
Page last reviewed: August 16, 2007 Historical Document

Content Source: Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention